Home / Recalls / SUN PHARMACEUTICAL INDUSTRIES INC / D-0891-2023

D-0891-2023 Class II Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

Recall Details

Product Type: Drugs
Report Date: July 5, 2023
Initiation Date: May 30, 2023
Termination Date: December 18, 2023
Voluntary/Mandated: N/A
Product Quantity: 12960 vials

Product Description

Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01

Reason for Recall

Subpotent drug

Distribution Pattern

USA nationwide

Code Information

Lot # BAD0089A, Exp 01/2025; BAD0330A, Exp 07/2025

Other recalls by SUN PHARMACEUTICAL INDUSTRIES INC

D-0476-2026 Class II — Fluocinonide, USP, 0.05% Cream, 30g tube, Rx only, Mfd by: Taro Pharmaceuticals (March 25, 2026)
D-0475-2026 Class II — Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals (March 25, 2026)
D-0477-2026 Class II — Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceuticals (March 25, 2026)
D-0342-2026 Class II — Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceu (January 27, 2026)
D-0256-2026 Class III — Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx o (December 30, 2025)
D-0257-2026 Class III — Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator (November 26, 2025)
D-0146-2026 Class II — Lisdexamfetamine Dimesylate Capsules, 30 mg, CII, 100-count bottle, Rx only, Man (October 28, 2025)
D-0145-2026 Class II — Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Man (October 28, 2025)
D-0147-2026 Class II — Lisdexamfetamine Dimesylate Capsules, 40 mg, CII, 100-count bottle, Rx only, Man (October 28, 2025)
D-0150-2026 Class II — Lisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, Man (October 28, 2025)